Customers & Industries: Captum Capital Industry: Pharmaceutical, Healthcare Product(s): Decisiontools Suite Application: iNPV of new companies and technologies Summary Captum Capital Limited, a life sciences and health care industry consulting company, specializes in the valuation of early stage companies. This process, especially in the life sciences sector, can be problematic because of the uncertainties in outcome, time to reach market, milestones, and the length of time to take a new drug to market. Biopharmaceutical development is a very high risk business – a new drug beginning clinical trials has only a 20% chance of ever reaching the market. Through using @RISK, Captum was able to value technology projects and to calculate Risk Adjusted Net Present Value. Decisiontools Suite Home C

Join for free to read